Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.4103/jphi.JPHI_31_17 http://scihub22266oqcxt.onion/10.4103/jphi.JPHI_31_17 C5553263!5553263!28929045     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Int+J+Pharm+Investig 2017 ; 7 (2): 41-6 Nephropedia Template TP {{tp|p=28929045|t=2017. Compensation to clinical trial participants in India: A gap analysis |pdf=|usr=}}{{28929045}} gab.com Text Compensation to clinical trial participants in India: A gap analysis JO: Int J Pharm Investig http://www.kidney.de/pget.php?&tw=1&pmid=28929045 #FOAvip The recent amendments notified by the Government of India, for conducting clinical trial, is greatly appreciable as promoting safety and well-being of human subjects. These rules clearly state that medical management of injuries in clinical trials is mandatory, and clinical trial-related injury or death needs to be compensated over and above the medical management. These rules need to be reconsidered for simplification and better understanding of issues regarding compensation. There is a need of clarity at some points which should be discussed with all stakeholders for better understanding of current regulations. In our view, attention must also be given to academic investigators, during discussion to promote availability of cost-effective treatment in India. Twit Text FOAVip Compensation to clinical trial participants in India: A gap analysis ????Int J Pharm Investig http://www.kidney.de/pget.php?&tw=1&pmid=28929045 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28929045 #FOAvip English Wikipedia <ref>{{Cite pmid|28929045}}</ref> Compensation to clinical trial participants in India: A gap analysis #MMPMID28929045 Urooj M; Husain GM; Khan MA; Kazmi MH Int J Pharm Investig 2017[Apr]; 7 (2): 41-6 PMID28929045show ga The recent amendments notified by the Government of India, for conducting clinical trial, is greatly appreciable as promoting safety and well-being of human subjects. These rules clearly state that medical management of injuries in clinical trials is mandatory, and clinical trial-related injury or death needs to be compensated over and above the medical management. These rules need to be reconsidered for simplification and better understanding of issues regarding compensation. There is a need of clarity at some points which should be discussed with all stakeholders for better understanding of current regulations. In our view, attention must also be given to academic investigators, during discussion to promote availability of cost-effective treatment in India. äCompensation to clinical trial participants in India: A gap analysis (epmc).pdf DeepDyve Pubget Overpricing